Cardiac Science boosted by GE defibrillator deal:
This article was originally published in Clinica
Executive Summary
Cardiac Science, an Irvine, California manufacturer of automated external cardiac defibrillators, has just signed a deal with global giant GE Medical Systems. GEMS' Information Technologies division will market Cardiac Science's products under its own name in markets outside the US. The agreement covers automated external defibrillators, as well as fully automatic defibrillator-monitors used in hospitals. Cardiac Science will also make a line of biphasic external defibrillators for exclusive sale by GEMS worldwide. It will start shipping products in autumn 2003. Cardiac Science recently reported a second-quarter net loss of $2m (down from $3.8m) on sales of $14.5m (+13%).
You may also be interested in...
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.